Working… Menu

A Study of Baricitinib (LY3009104) in Participants With COVID-19 (COV-BARRIER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04421027
Recruitment Status : Completed
First Posted : June 9, 2020
Last Update Posted : July 19, 2021
Information provided by (Responsible Party):
Eli Lilly and Company